Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Risako Takaya"'
Publikováno v:
BMC Health Services Research, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Resistant bacterial infections, particularly those caused by gram-negative pathogens, are associated with high mortality and economic burdens. Ceftolozane/tazobactam demonstrated efficacy comparable to meropenem in patients with v
Externí odkaz:
https://doaj.org/article/a8dff5c954aa47928cb219cb8dfc6a54
Autor:
Takuya Ozawa, Ho Namkoong, Risako Takaya, Yusuke Takahashi, Koichi Fukunaga, Yuki Enoki, Kazuaki Taguchi, Junko Kizu, Kazuaki Matsumoto, Naoki Hasegawa
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background In Japan, Mycobacterium avium complex lung disease (MAC-LD) is the most common in nontuberculous mycobacterial lung disease. Patients often experience adverse events, resulting in the discontinuation of treatment, which causes tre
Externí odkaz:
https://doaj.org/article/ac3fec8292de4e87910e19874001e2dd
Publikováno v:
BPB Reports. 3:1-6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a1618a1c20619501fa250bc5b754a9e
https://doi.org/10.1248/bpbreports.3.1_1
https://doi.org/10.1248/bpbreports.3.1_1
Publikováno v:
Open Forum Infectious Diseases
Background Increase of carbapenem-resistant Enterobacterales (CRE) is a serious problem in the clinical setting and drugs which can treat patients with CRE are still limited. Nacubactam (OP0595) is a novel diazabicyclooctane-type β-lactamase inhibit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0063b87af053fd29435e7360082d6202
http://europepmc.org/articles/PMC8644807
http://europepmc.org/articles/PMC8644807